Glibenclamide prevents diabetes in NOD Mice

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Lamprianou, Smaragda ^a   Gysemans, Conny ^b   Saab, Joanna Bou ^a   Pontes, Helena ^a   Mathieu, Chantal ^b   Meda, Paolo ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CONNEXIN 36; GLIBENCLAMIDE; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; ANTIDIABETIC AGENT; CYTOKINE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TH1 CELL; ANIMAL; CELL CULTURE; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; IMMUNOLOGY; INSULINOMA; METABOLISM; NONOBESE DIABETIC MOUSE;

ANIMALS; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; GLYBURIDE; HYPOGLYCEMIC AGENTS; INSULIN-SECRETING CELLS; INSULINOMA; MICE; MICE, INBRED NOD;

EID: 85007278278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168839     Document Type: Article

References (30)

1. Ashcroft FM RP (2013) K(ATP) channels and islet hormone secretion: new insights and controversies. Nat Rev Endocrinol 9: 660-669. doi: 10.1038/nrendo.2013.166 PMID: 24042324
2. Bavamian S PH, Cancela J, Charollais A, Startchik S, Van de Ville D, Meda P. (2012) The intercellular synchronization of Ca2+ oscillations evaluates Cx36-dependent coupling. PLoS One 7: e41535. doi: 10.1371/journal.pone.0041535 PMID: 22848521
3. Charpantier E CJ, Meda P. (2007) Beta cells preferentially exchange cationic molecules via connexin 36 gap junction channels. Diabetologia 50: 2332-2341. doi: 10.1007/s00125-007-0807-9 PMID: 17828386
4. Meda P HP, Perrelet A, Renold AE, Orci L. (1980) Gap junction development is correlated with insulin content in the pancreatic B cell. Science 209: 1026-1028 PMID: 6773144
5. Meda P PA, Orci L. (1979) Increase of gap junctions between pancreatic B-cells during stimulation of insulin secretion. J Cell Biol 82: 441-448. PMID: 113418
6. Eizirik DL CM, Ortis F. (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5: 219-226. doi: 10.1038/nrendo.2009.21 PMID: 19352320
7. Hosszufalusi N RL, Takei S, Chan E, Charles MA. (1994) Glipizide-induced prevention of diabetes and autoimmune events in the BB rat. J Autoimmun 7: 753-761. doi: 10.1006/jaut.1994.1059 PMID: 7888033
8. Williams AJ BP, Krug J, Procaccini E, Signore A, Xu S, Gale EA et al. (1993) Tolbutamide reduces the incidence of diabetes mellitus, but not insulitis, in the non-obese-diabetic mouse. Diabetologia 36: 487-492. PMID: 8335169
9. Ansar MM AA (2006) Nitric oxide involvement in pancreatic beta cell apoptosis by glibenclamide. Nitric Oxide 14: 39-44. doi: 10.1016/j.niox.2005.09.002 PMID: 16256381
10. Kwon MJ CH, Yoon CS, Lee EJ, Kim TK, Lee SH, Ko KS, et al. (2013) Low glibenclamide concentrations affect endoplasmic reticulum stress in INS-1 cells under glucotoxic or glucolipotoxic conditions. Korean J Intern Med 28: 339-346. doi: 10.3904/kjim.2013.28.3.339 PMID: 23682228
11. Sawada F IT, Tsubouchi H, Sasaki S, Fujii M, Maeda Y, Morinaga H, et al. (2008) Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6. Metabolism 57: 1038-1045. doi: 10.1016/j.metabol.2008.01.038 PMID: 18640379
12. Tochino Y. (1987) The NOD mouse as a model of type I diabetes. Crit Rev Immunol 8: 49-81. PMID: 2961513
13. Rendell M. (2004) The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs 64: 1339-1358. PMID: 15200348
14. Chahal A (2011) Comparative safety and efficacy of glibenclamide in the elderly. http://www.who.int/ selection-medicines/committees/expert/19/applications/Sulfonylurea
15. Klee P AF, Pontes H, Cederroth M, Charollais A, Caille D, Britan A, et al. (2011) Connexins protect mouse pancreatic β cells against apoptosis. J Clin Invest 121: 4870-4879. doi: 10.1172/JCI40509 PMID: 22056383
16. Berggren EK BK (2013) Oral agents for the management of gestational diabetes. Clin Obstet Gynecol 56: 827-836. doi: 10.1097/GRF.0b013e3182a8e0a5 PMID: 24005130
17. Jörns A AT, Meyer zu Vilsendorf A, Klempnauer J, Wedekind D, Hedrich HJ, Marselli L, et al. (2014) Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia 57: 512-521. doi: 10.1007/ s00125-013-3125-4 PMID: 24310561
18. Allagnat F KP, Cardozo AK, Meda P, Haefliger JA. (2013) Connexin36 contributes to INS-1E cells survival through modulation of cytokine-induced oxidative stress, ER stress and AMPK activity. Cell Death Differ 20: 1742-1752. doi: 10.1038/cdd.2013.134 PMID: 24096873
19. Jayasimhan A MK, Slattery RM. (2014) Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse. Clin Sci (Lond) 126: 1-18.
20. Cigliola V CV, Arabieter W, Meda P. (2013) Connexins and β-cell functions. Diabetes Res Clin Pract 99: 250-259. doi: 10.1016/j.diabres.2012.10.016 PMID: 23176806
21. Serre-Beinier V BD, Zulianello L, Charollais A, Caille D, Charpantier E, Gauthier BR, et al. (2009) Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression. Hum Mol Genet 18: 428-439. doi: 10.1093/hmg/ddn370 PMID: 19000992
22. Yu J, Zhou X, Chang M, Nakaya M, Chang JH, Xiao Y, et al. (2015) Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation. Nat Commun. 6: 6074. doi: 10.1038/ ncomms7074 PMID: 25606824
23. Debes GF, Arnold CN, Young AJ, Krautwald S, Lipp M, Hay JB, et al. (2005) Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat Immunol. 6:889-894. doi: 10.1038/ ni1238 PMID: 16116468
24. Bromley SK, Thomas SY, Luster AD. (2005) Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol. 6:895-901. doi: 10.1038/ni1240 PMID: 16116469
25. David R, Ma L, Ivetic A, Takesono A, Ridley AJ, Chai JG, et al. (2009) T-cell receptor- and CD28-induced Vav1 activity is required for the accumulation of primed T cells into antigenic tissue. Blood 113:3696-3705. doi: 10.1182/blood-2008-09-176511 PMID: 19060239
26. Radenkovic M, Silver C, Arvastsson J, Lynch K, Lernmark Å, Harris RA, et al. (2016) Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA). Clin Exp Immunol. 186:46-56.27. doi: 10.1111/cei.12834 PMID: 27357431
27. Koh GC, Maude RR, Schreiber MF, Limmathurotsakul D, Wiersinga WJ, Wuthiekanun V, et al. (2011) Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis. 52: 717-725. doi: 10.1093/cid/ciq192 PMID: 21293047
28. Grishman EK, White PC, Savani RC. (2012) Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes. Pediatr Res. 71:626-632. doi: 10. 1038/pr.2012.24 PMID: 22337228
29. Elding Larsson H, Vehik K, Gesualdo P, Akolkar B, Hagopian W, Krischer J, et al. (2014) Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes. 15: 118-126. doi: 10.1111/pedi.12066 PMID: 24034790
30. Eringsmark Regnéll S, Lernmark A. (2013) The environment and the origins of islet autoimmunity and Type 1 diabetes. Diabet Med. 30: 155-160. doi: 10.1111/dme.12099 PMID: 23252770